awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41476579-187F8D08-EE9B-4D71-AD1A-58016A3E64EC
Q41476579-187F8D08-EE9B-4D71-AD1A-58016A3E64EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41476579-187F8D08-EE9B-4D71-AD1A-58016A3E64EC
Clinical implications of canagliflozin treatment in patients with type 2 diabetes.
P2860
Q41476579-187F8D08-EE9B-4D71-AD1A-58016A3E64EC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41476579-187F8D08-EE9B-4D71-AD1A-58016A3E64EC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c2ba109d713ebd724e29423e58affbcac3d0f17c
P2860
Ipragliflozin and other sodium-glucose cotransporter-2 (SGLT2) inhibitors in the treatment of type 2 diabetes: preclinical and clinical data.